Company Snapshot

Read it, Learn it and Do it for your investment Needs
Company News Details
Pfizer Ltd
Pharmaceuticals - Multinational
BSE Code: 500680 NSE Symbol: PFIZER P/E : 28.35
ISIN Demat: INE182A01018 Div & Yield %: 3.5 EPS : 166.47
Book Value: 841.20 Market Cap (Rs. Cr.): 21,591.79 Face Value : 10
Pfizer announces change in senior management Back
(20 Jan 2026)

Pfizer announced the following change in senior management:

  • Nilesh Pendse is appointed as Category Lead – Vaccines of the Company with effect from 01 February 2026. Pendse shall accordingly be a Senior Management Personnel of the Company effective the said date.
  • Manikantan Seshadrinathan – Category Lead, Hospitals & Rare Disease will transition to another role within the Pfizer Group Companies effective 01 February 2026, and shall accordingly cease to be a Senior Management Personnel of the Company effective 31 January 2026.
  • Prashant Mahalingam, Category Lead – Internal Medicine, will take up additional responsibility of the Hospitals Business of the Company and shall be redesignated as Category Lead – Internal Medicine & Hospitals, effective 01 February 2026.